SCHEDULE: FMR LLC Reports 5.8% Stake in QuidelOrtho Corp

FMR LLC and Abigail P. Johnson have jointly filed a Schedule 13G, reporting beneficial ownership of 5.8% of QuidelOrtho Corp's common stock as of September 30, 2026.

Summary

• FMR LLC and Abigail P. Johnson have filed an amendment to their Schedule 13G, reporting their beneficial ownership of QuidelOrtho Corp's common stock.
• As of September 30, 2026, the reporting persons collectively beneficially owned 3,950,167.67 shares, representing 5.8% of the class of securities.
• FMR LLC holds sole voting power over 3,945,240 shares and sole dispositive power over 3,950,167.67 shares.
• Abigail P. Johnson shares sole dispositive power over 3,950,167.67 shares.
• The filing indicates that other persons have the right to receive or direct the sale of dividends, but no single other person's interest exceeds five percent.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, primarily indicating a significant but stable institutional ownership stake without immediate strategic shifts.

Positives

• FMR LLC, a significant institutional investor, maintains a substantial ownership stake of 5.8% in QuidelOrtho Corp.
• The filing confirms a stable and significant institutional presence, which can be viewed positively by the market.

Negatives

• The filing does not provide any new strategic information or performance metrics, making it a routine disclosure.

Risks

• The filing does not explicitly mention any new risks or challenges.
• Potential future changes in FMR LLC's investment strategy could impact QuidelOrtho Corp's stock.

Future Outlook

This filing is a routine disclosure of beneficial ownership and does not contain forward-looking statements or specific future guidance from the company.

Management Comments

• FMR LLC and Abigail P. Johnson certify that the securities were acquired and are held in the ordinary course of business and were not acquired or held for the purpose of or with the effect of changing or influencing the control of the issuer.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are common for institutional investors accumulating significant stakes. This filing indicates FMR LLC's continued substantial investment in the diagnostics and medical device sector, represented by QuidelOrtho Corp.

Comparison to Industry Standards

• Institutional ownership stakes of 5.8% are common for large-cap companies in the healthcare sector.
• FMR LLC is a major asset manager, and its holdings are typically diversified across various sectors, with significant positions in healthcare being standard practice.

Stakeholder Impact

• Shareholders: The continued significant ownership by FMR LLC may provide a degree of stability and confidence in the company's long-term prospects.
• Management: The filing confirms that FMR LLC is not seeking to influence control, which is a standard assurance for institutional investors.

Next Steps

• FMR LLC and Abigail P. Johnson will continue to monitor their investment in QuidelOrtho Corp.
• Future amendments to the Schedule 13G will be filed if there are material changes in beneficial ownership.

Key Dates

Keywords

QuidelOrtho Corp, FMR LLC, Schedule 13G, Institutional Ownership, Common Stock, Beneficial Ownership, Investment Management